The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in Duchenne patients who can still walk, however.

United Therapeutics (UTHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Roche Holding AG said on Tuesday it has paused all shipments of muscular disorder gene therapy Elevidys outside the U.S., ...

Tulavi Therapeutics, a private medical technology company focused on advancing surgical solutions that address critical unmet ...

The cancer pain market, valued at USD 6.53 billion in 2024, is projected to reach USD 11.81 billion by 2034, with a CAGR of 6 ...

Logo Chill Factor Cooling & Heating offers 10% off HVAC services for military and first responders in Norco, CA. Trusted lo ...

USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Dispatch seeks to address two main challenges of immunotherapies in solid tumors: the lack of a target and the ...